Arzneimittelforschung 1993;43:1359-62
Gastroenterology 132 (Suppl
NovoCare self-pay program Novo Nordisk's NovoCare program offers a self-pay price of approximately $199 per month for the starting doses (0.25/0.5 mg, first two fills through December 31, 2026), then approximately $349 per month for standard injection doses
For breastfeeding moms who worry that taking semaglutide might also cause appetite suppression and weight loss for the baby, Krutsch says her research shows the drug doesn't get into breast milk
For those not on GLP-1 drugs, the products ingredients can also help them feel fuller, Langer said
Medicare and Medicaid are not accepted, and insurance reimbursement is not available for services provided through the platform